Priority Date: 27.02.12 (US 201261603650P)

REPROGRAMMING EFFECTOR PROTEIN INTERACTIONS TO CORRECT EPIGENETIC DEFECTS IN CANCER

  • Application ID: EP13754077
  • Status: EXAMINATION IN PROGRESS

Attorney

Employment test 201 - 500 employees
Company dna zacco
operating since 2001
Headquarter in Copenhagen and 15 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and G01 (MEASURING; TESTING). We found, that Coller IP Management Ltd, TransMIT GmbH, Kailuweit & Uhlemann, Bock Bieber Donath, Dr. Emil Benatov & Partners - Bulgarian Patent Attorney & Licensed Appraiser and 173 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 27.02.2012 - Priority Date (US 201261603650P)
  • 06.09.2013 - Publication A1 (WO2013127011)
  • 07.01.2015 - Publication A1 (EP2819662)